Results 231 to 240 of about 1,610,408 (351)

Noninvasive cardiac radiation for ablation of ventricular tachycardia [PDF]

, 2017
Cooper, Daniel, Cuculich, Phillip S, Faddis, Mitchell, Gleva, Marye, Hallahan, Dennis, Kashani, Rojano, Lang, Adam, Mutic, Sasa, Noheria, Amit, Robinson, Clifford G, Rudy, Yoram, Schill, Matthew R, Smith, Timothy W   +12 more
core   +2 more sources

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

The Rhythms of the Moon: Can the Moon Affect Cardiac Arrhythmias? [PDF]

J Innov Card Rhythm Manag
Ziakos A, Sause A, Seyfarth M.
europepmc   +1 more source

Non-invasive assessment in cardiac arrhythmias 1 [PDF]

, 2005

openalex   +1 more source

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí

Europace, 2017
G. Lip, A. Coca, T. Kahan, G. Boriani, A. Manolis, M. Olsen, A. Oto, T. Potpara, J. Steffel, F. Marín, M. J. de Oliveira Figueiredo, G. de Simone, Wendy S. Tzou, C. Chiang, B. Williams, G. Dan, B. Gorenek, L. Fauchier, I. Savelieva, R. Hatala, I. V. Van Gelder, Jana Brguljan-Hitij, S. Erdine, D. Lovic, Young-Hoon Kim, Jorge Salinas-Arce, Michael Field   +26 more
semanticscholar   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Hematological disruptions in HIV-positive individuals with cardiac arrhythmias: a focus on coagulation and inflammation - a narrative review. [PDF]

Ann Med Surg (Lond)
Obeagu EI, Goryacheva OG, Mamedov M.
europepmc   +1 more source

Irreversible electroporation for the treatment of cardiac arrhythmias

Expert Review of Cardiovascular Therapy, 2018
A. Sugrue, E. Maor, A. Ivorra, Vaibhav R. Vaidya, Chance M. Witt, S. Kapa, S. Asirvatham   +6 more
semanticscholar   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source